Midkine in nephrogenesis, hypertension and kidney diseases

British Journal of Pharmacology

Volumn 171, Issue 4, 2014, Pages 879-887

  Sato, Waichi ^a   Sato, Yuka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

acute kidney injury (AKI); chronic kidney injury (CKD); hypertension; inflammation; midkine; nephrogenesis; renin Angiotensin system (RAS)

Indexed keywords

ANGIOTENSIN II; CADMIUM; CISPLATIN; DIPEPTIDYL CARBOXYPEPTIDASE; MIDKINE; PUROMYCIN AMINONUCLEOSIDE; REACTIVE OXYGEN METABOLITE;

ACUTE KIDNEY FAILURE; ANGIOTENSIN BLOOD LEVEL; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; FIBRIN DEPOSITION; GLOMERULOSCLEROSIS; HEMODIALYSIS; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY DEVELOPMENT; KIDNEY INJURY; KIDNEY ISCHEMIA; MEAN ARTERIAL PRESSURE; NEPHROSIS; NEPHROTOXICITY; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; REVIEW; SYSTOLIC BLOOD PRESSURE;

ACUTE KIDNEY INJURY (AKI); CHRONIC KIDNEY INJURY (CKD); HYPERTENSION; INFLAMMATION; MIDKINE; NEPHROGENESIS; RENIN-ANGIOTENSIN SYSTEM (RAS);

ANIMALS; CYTOKINES; EMBRYONIC DEVELOPMENT; HUMANS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; RENIN-ANGIOTENSIN SYSTEM;

EID: 84893052463     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12418     Document Type: Review

References (60)

1. Adachi Y, Matsubara S, Pedraza C, Ozawa M, Tsutsui J, Takamatsu H, et al. (1996). Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1). Oncogene 13: 2197-2203.
2. Antunes G, Neville E, (2000). Management of malignant pleural effusions. Thorax 55: 981-983.
3. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. (2001). Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869.
4. Caulfield JP, Reid JJ, Farquhar MG, (1976). Alterations of the glomerular epithelium in acute aminonucleoside nephrosis. Evidence for formation of occluding junctions and epithelial cell detachment. Lab Invest 34: 43-59.
5. Chen S, Bu G, Takei Y, Sakamoto K, Ikematsu S, Muramatsu T, et al. (2007). Midkine and LDL-receptor-related protein 1 contribute to the anchorage-independent cell growth of cancer cells. J Cell Sci 120 (Pt 22): 4009-4015.
6. Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I, Wang ZY, (2002). Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 397: 162-171.
7. Diamond-Stanic MK, Romero-Aleshire MJ, Hoyer PB, Greer K, Hoying JB, Brooks HL, (2011). Midkine, a heparin-binding protein, is increased in the diabetic mouse kidney postmenopause. Am J Physiol Renal Physiol 300: F139-F146.
8. Eddy AA, Fogo AB, (2006). Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol 17: 2999-3012.
9. Ezquerra L, Herradon G, Nguyen T, Silos-Santiago I, Deuel TF, (2005). Midkine, a newly discovered regulator of the renin-Angiotensin pathway in mouse aorta: significance of the pleiotrophin/midkine developmental gene family in angiotensin II signaling. Biochem Biophys Res Commun 333: 636-643.
10. Ferrari P, (2007). Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease. Nephrology (Carlton) 12: 81-89.
11. Fujisawa K, Matsumoto Y, Muramatsu H, Shinzato T, Hiramatsu K, Horie K, et al. (1998). Increased serum midkine levels during hemodialysis using heparin in chronic renal failure. J Biochem 123: 864-869.
12. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T, (2005). Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28: 164-176.
13. Hertig A, Rondeau E, (2004). Role of the coagulation/fibrinolysis system in fibrin-Associated glomerular injury. J Am Soc Nephrol 15: 844-853.
14. Hobo A, Yuzawa Y, Kosugi T, Kato N, Asai N, Sato W, et al. (2009). The growth factor midkine regulates the renin-Angiotensin system in mice. J Clin Invest 119: 1616-1625.
15. Hoke TS, Douglas IS, Klein CL, He Z, Fang W, Thurman JM, et al. (2007). Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol 18: 155-164.
16. Horiba M, Kadomatsu K, Nakamura E, Muramatsu H, Ikematsu S, Sakuma S, et al. (2000). Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest 105: 489-495.
17. Hory B, Drueke TB, (1997). The parathyroid-bone axis in uremia: new insights into old questions. Curr Opin Nephrol Hypertens 6: 40-48.
18. Hsueh WA, Wyne K, (2011). Renin-Angiotensin-Aldosterone system in diabetes and hypertension. J Clin Hypertens (Greenwich) 13: 224-237.
19. Jarmalavičiūtė A, Tunaitis V, Strainienė E, Aldonytė R, Ramanavičius A, Venalis A, et al. (2013). A new experimental model for neuronal and glial differentiation using stem cells derived from human exfoliated deciduous teeth. J Mol Neurosci (Epub ahead of print).
20. Johnson RJ, Feig DI, Nakagawa T, Sanchez-Lozada LG, Rodriguez-Iturbe B, (2008). Pathogenesis of essential hypertension: historical paradigms and modern insights. J Hypertens 26: 381-391.
21. Kadomatsu K, Muramatsu T, (2004). Midkine and pleiotrophin in neural development and cancer. Cancer Lett 204: 127-143.
22. Kaplan F, Comber J, Sladek R, Hudson TJ, Muglia LJ, Macrae T, et al. (2003). The growth factor midkine is modulated by both glucocorticoid and retinoid in fetal lung development. Am J Respir Cell Mol Biol 28: 33-41.
23. Kato K, Kosugi T, Sato W, Arata-Kawai H, Ozaki T, Tsuboi N, et al. (2011). Growth factor Midkine is involved in the pathogenesis of renal injury induced by protein overload containing endotoxin. Clin Exp Nephrol 15: 346-354.
24. Kawai H, Sato W, Yuzawa Y, Kosugi T, Matsuo S, Takei Y, et al. (2004). Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage. Am J Pathol 165: 1603-1612.
25. Kitching AR, Holdsworth SR, Ploplis VA, Plow EF, Collen D, Carmeliet P, et al. (1997). Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 185: 963-968.
26. Kobori H, Nishiyama A, Abe Y, Navar LG, (2003). Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 41: 592-597.
27. Kojima H, Kosugi T, Sato W, Sato Y, Maeda K, Kato N, et al. (2013). Deficiency of growth factor midkine exacerbates necrotizing glomerular injuries in progressive glomerulonephritis. Am J Pathol 182: 410-419.
28. Kosugi T, Yuzawa Y, Sato W, Kawai H, Matsuo S, Takei Y, et al. (2006). Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. Am J Pathol 168: 9-19.
29. Kosugi T, Yuzawa Y, Sato W, Arata-Kawai H, Suzuki N, Kato N, et al. (2007). Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy. Lab Invest 87: 903-913.
30. Kosugi T, Heinig M, Nakayama T, Connor T, Yuzawa Y, Li Q, et al. (2009). Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice. Am J Pathol 174: 1221-1229.
31. Lauriat S, Linas SL, (1998). The role of neutrophils in acute renal failure. Semin Nephrol 18: 498-504.
32. Matsubara S, Take M, Pedraza C, Muramatsu T, (1994). Mapping and characterization of a retinoic acid-responsive enhancer of midkine, a novel heparin-binding growth/differentiation factor with neurotrophic activity. J Biochem 115: 1088-1096.
33. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, et al. (2002). Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: E58-E65.
34. Muramatsu T, (1993). Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation. Int J Dev Biol 37: 183-188.
35. Muramatsu T, (2002). Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem 132: 359-371.
36. Naicker S, Fabian J, Naidoo S, Wadee S, Paget G, Goetsch S, (2007). Infection and glomerulonephritis. Semin Immunopathol 29: 397-414.
37. Nakagawa T, Tanabe K, Croker BP, Johnson RJ, Grant MB, Kosugi T, et al. (2011). Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat Rev Nephrol 7: 36-44.
38. Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA, (2011). Intratubular renin-Angiotensin system in hypertension. Hypertension 57: 355-362.
39. Nobakht N, Kamgar M, Rastogi A, Schrier RW, (2011). Limitations of angiotensin inhibition. Nat Rev Nephrol 7: 356-359.
40. Okubo S, Niimura F, Matsusaka T, Fogo A, Hogan BL, Ichikawa I, (1998). Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorption. Kidney Int 53: 617-625.
41. Padanilam BJ, (2003). Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 284: F608-F627.
42. Prieto-Carrasquero MC, Botros FT, Kobori H, Navar LG, (2009). Collecting Duct Renin: a major player in Angiotensin II-dependent Hypertension. J Am Soc Hypertens 3: 96-104.
43. Pupilli C, Chevalier RL, Carey RM, Gomez RA, (1992). Distribution and content of renin and renin mRNA in remnant kidney of adult rat. Am J Physiol 263 (4 Pt 2): F731-F738.
44. Qiu L, Hyink DP, Gans WH, Amsler K, Wilson PD, Burrow CR, (2004). Midkine promotes selective expansion of the nephrogenic mesenchyme during kidney organogenesis. Organogenesis 1: 14-21.
45. Remuzzi G, Ruggenenti P, Benigni A, (1997). Understanding the nature of renal disease progression. Kidney Int 51: 2-15.
46. Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA, (2004). Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 279: 37124-37132.
47. Ruggenenti P, Cravedi P, Remuzzi G, (2010). The RAAS in the pathogenesis and treatment of diabetic nephropathy. Nat Rev Nephrol 6: 319-330.
48. Sakamoto K, Bu G, Chen S, Takei Y, Hibi K, Kodera Y, et al. (2011). Premature ligand-receptor interaction during biosynthesis limits the production of growth factor midkine and its receptor LDL receptor-related protein 1. J Biol Chem 286: 8405-8413.
49. Satarug S, Baker JR, Reilly PE, Esumi H, Moore MR, (2000). Evidence for a synergistic interaction between cadmium and endotoxin toxicity and for nitric oxide and cadmium displacement of metals in the kidney. Nitric Oxide 4: 431-440.
50. Sato W, Kadomatsu K, Yuzawa Y, Muramatsu H, Hotta N, Matsuo S, et al. (2001). Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol 167: 3463-3469.
51. Sato W, Yuzawa Y, Kadomatsu K, Tayasu T, Muramatsu H, Muramatsu T, et al. (2002). Midkine expression in the course of nephrogenesis and its role in ischaemic reperfusion injury. Nephrol Dial Transplant 17 (Suppl 9): 52-54.
52. Sato W, Takei Y, Yuzawa Y, Matsuo S, Kadomatsu K, Muramatsu T, (2005). Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusion. Kidney Int 67: 1330-1339.
53. Schrier RW, Wang W, Poole B, Mitra A, (2004). Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114: 5-14.
54. Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, et al. (2009). Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy. Nephrol Dial Transplant 24: 1162-1169.
55. Suzuki A, Ito T, Imai E, Yamato M, Iwatani H, Kawachi H, et al. (2003). Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats. J Am Soc Nephrol 14: 981-991.
56. Takada J, Ooboshi H, Ago T, Kitazono T, Yao H, Kadomatsu K, et al. (2005). Postischemic gene transfer of midkine, a neurotrophic factor, protects against focal brain ischemia. Gene Ther 12: 487-493.
57. Tsutsui J, Uehara K, Kadomatsu K, Matsubara S, Muramatsu T, (1991). A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse. Biochem Biophys Res Commun 176: 792-797.
58. Vilar J, Lalou C, Duong Van Huyen JP, Charrin S, Hardouin S, Raulais D, et al. (2002). Midkine is involved in kidney development and in its regulation by retinoids. J Am Soc Nephrol 13: 668-676.
59. Vinik A, Ullal J, Parson HK, Casellini CM, (2006). Diabetic neuropathies: clinical manifestations and current treatment options. Nat Clin Pract Endocrinol Metab 2: 269-281.
60. Zhang W, Chen X, Shi S, Wei R, Wang J, Yamanaka N, et al. (2005). Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril. Nephrol Dial Transplant 20: 892-901.